Ann Hanham
Board Member @SCYNEXIS, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Board Member @SCYNEXIS, Inc.
Jersey City, NJ, US
SCYNEXIS (NASDAQ: SCYX).SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. SCYNEXIS scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. The company is developing their lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. Additional information:
EDUCATION
The University of British Columbia
PhD
SKILLS
ABOUT ANN HANHAM
Specialties: Board member (public and private), life sciences investing.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.